NovaBay®Pharmaceuticals, Inc. announced the appointments of Audrey Kunin, M.D. and Julie Garlikov to the NovaBay Board of Directors. NovaBay also announces the resignation of Zhang Xinzhou (Paul) Li as a director. His vacancy is being filled by Yongxiang (Sean) Zheng.

All changes to the Board of Directors are effective immediately and result in an increase to the size of NovaBay's Board from six to eight members.